Skip to main content
Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin 7/2020

06.11.2019 | Originalien

Fluid resuscitation after severe trauma injury

U-shaped associations between tetrastarch dose and survival time or frequency of acute kidney failure

verfasst von: E. Fleischhacker, H. Trentzsch, D. Kuppinger, S. Piltz, F. Beyer, F. Meigel, T. Kammerer, M. Rehm, W. H. Hartl, MD

Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Using tetrastarch for fluid resuscitation after a severe trauma injury may increase risks of death and acute kidney injury. The importance of tetrastarch dose, however, is unknown.

Methods

A retrospective observational study was performed in two trauma centres using data on type and amount of fluids (balanced crystalloids or tetrastarch) used for pre- and acute in-hospital shock management. We evaluate independent associations between the relative and absolute volumes of tetrastarch and 90-day survival time or the frequency of severe acute kidney failure (AKF).

Results

We studied 271 patients who had sustained a severe blunt trauma injury (average predicted mortality according to the Revised Injury Severity Classification Score (RISC) 15.1 ± 1.4% [mean, standard deviation]), and who had required more than 2 days of intensive care therapy. In all, 75.3% of patients had received tetrastarch with a crystalloid/colloid ratio of 2.93 ± 2.60. The 90-day mortality was 11.1%, and 7.8% of the patients developed severe AKF. After adjusting for confounders, we found a U-shaped, nonlinear association between absolute or relative volumes of tetrastarch and survival time (p = 0.003 and 0.025, respectively). Optimal relative volumes of tetrastarch approximately ranged from 20 to 30% of total fluids. Giving less than about 1000 ml, or more than about 2000 ml tetrastarch was significantly associated with an increased risk of developing severe AKF (p = 0.023).

Conclusions

There was a complex U‑shaped association between the tetrastarch dose and morbidity/mortality of patients after a severe trauma injury. The optimal crystalloid/tetrastarch ratio for acute shock management appears to range from about 2.5 to 4.0.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wiedermann CJ, Eisendle K (2017) Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency. J Pharm Policy Pract 10:12PubMedPubMedCentral Wiedermann CJ, Eisendle K (2017) Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency. J Pharm Policy Pract 10:12PubMedPubMedCentral
4.
Zurück zum Zitat Bellomo R, Bion J, Finfer S, Myburgh J, Perner A, Reinhart K (2014) Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 112(3):595–600PubMed Bellomo R, Bion J, Finfer S, Myburgh J, Perner A, Reinhart K (2014) Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 112(3):595–600PubMed
5.
Zurück zum Zitat Coriat P, Guidet B, de Hert S, Kochs E, Kozek S, Van Aken H (2014) Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 113(1):194–195PubMed Coriat P, Guidet B, de Hert S, Kochs E, Kozek S, Van Aken H (2014) Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 113(1):194–195PubMed
6.
Zurück zum Zitat Doshi P (2018) EMA recommendation on hydroxyethyl starch solutions obscured controversy. BMJ 360:k1287PubMed Doshi P (2018) EMA recommendation on hydroxyethyl starch solutions obscured controversy. BMJ 360:k1287PubMed
7.
Zurück zum Zitat Marx G, Schindler AW, Mosch C, Albers J, Bauer M, Gnass I, Hobohm C, Janssens U, Kluge S, Kranke P, Maurer T, Merz W, Neugebauer E, Quintel M, Senninger N, Trampisch HJ, Waydhas C, Wildenauer R, Zacharowski K, Eikermann M (2016) Intravascular volume therapy in adults: guidelines from the Association of the Scientific Medical Societies in Germany. Eur J Anaesthesiol 33(7):488–521PubMedPubMedCentral Marx G, Schindler AW, Mosch C, Albers J, Bauer M, Gnass I, Hobohm C, Janssens U, Kluge S, Kranke P, Maurer T, Merz W, Neugebauer E, Quintel M, Senninger N, Trampisch HJ, Waydhas C, Wildenauer R, Zacharowski K, Eikermann M (2016) Intravascular volume therapy in adults: guidelines from the Association of the Scientific Medical Societies in Germany. Eur J Anaesthesiol 33(7):488–521PubMedPubMedCentral
8.
Zurück zum Zitat Perner A, Junttila E, Haney M, Hreinsson K, Kvåle R, Vandvik PO, Møller MH (2015) Scandinavian clinical practice guideline on choice of fluid in resuscitation of critically ill patients with acute circulatory failure. Acta Anaesthesiol Scand 59(3):274–285PubMed Perner A, Junttila E, Haney M, Hreinsson K, Kvåle R, Vandvik PO, Møller MH (2015) Scandinavian clinical practice guideline on choice of fluid in resuscitation of critically ill patients with acute circulatory failure. Acta Anaesthesiol Scand 59(3):274–285PubMed
9.
Zurück zum Zitat Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer EA, Ozier Y, Riddez L, Schultz A, Vincent JL, Spahn DR (2016) The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 12;20:100 Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer EA, Ozier Y, Riddez L, Schultz A, Vincent JL, Spahn DR (2016) The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 12;20:100
11.
Zurück zum Zitat Kieninger M, Unbekannt D, Schneiker A, Sinner B, Bele S, Prasser C (2017) Effect of hydroxyethyl starch solution on incidence of acute kidney injury in patients suffering from cerebral Vasospasm following aneurysmal subarachnoid hemorrhage. Neurocrit Care 26(1):34–40PubMed Kieninger M, Unbekannt D, Schneiker A, Sinner B, Bele S, Prasser C (2017) Effect of hydroxyethyl starch solution on incidence of acute kidney injury in patients suffering from cerebral Vasospasm following aneurysmal subarachnoid hemorrhage. Neurocrit Care 26(1):34–40PubMed
12.
Zurück zum Zitat Kunze E, Stetter C, Willner N, Koehler S, Kilgenstein C, Ernestus RI, Kranke P, Muellenbach RM, Westermaier T (2016) Effects of fluid treatment with hydroxyethyl starch on renal function in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 28(3):187–194PubMed Kunze E, Stetter C, Willner N, Koehler S, Kilgenstein C, Ernestus RI, Kranke P, Muellenbach RM, Westermaier T (2016) Effects of fluid treatment with hydroxyethyl starch on renal function in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 28(3):187–194PubMed
13.
Zurück zum Zitat Ma PL, Peng XX, Du B, Hu XL, Gong YC, Wang Y, Xi XM (2015) Sources of heterogeneity in trials reporting hydroxyethyl starch 130/0.4 or 0.42 associated excess mortality in septic patients: a systematic review and meta-regression. Chin Med J (Engl) 128(17):2374–2382 Ma PL, Peng XX, Du B, Hu XL, Gong YC, Wang Y, Xi XM (2015) Sources of heterogeneity in trials reporting hydroxyethyl starch 130/0.4 or 0.42 associated excess mortality in septic patients: a systematic review and meta-regression. Chin Med J (Engl) 128(17):2374–2382
14.
Zurück zum Zitat Leberle R, Ernstberger A, Loibl M, Merkl J, Bunz M, Creutzenberg M, Trabold B (2015) Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients. Injury 46(1):105–109PubMed Leberle R, Ernstberger A, Loibl M, Merkl J, Bunz M, Creutzenberg M, Trabold B (2015) Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients. Injury 46(1):105–109PubMed
15.
Zurück zum Zitat Mutter TC, Ruth CA, Dart AB (2013) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 7:CD7594 Mutter TC, Ruth CA, Dart AB (2013) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 7:CD7594
16.
Zurück zum Zitat Hand WR, Whiteley JR, Epperson TI, Tam L, Crego H, Wolf B, Chavin KD, Taber DJ (2015) Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review. Anesth Analg 120(3):619–626PubMedPubMedCentral Hand WR, Whiteley JR, Epperson TI, Tam L, Crego H, Wolf B, Chavin KD, Taber DJ (2015) Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review. Anesth Analg 120(3):619–626PubMedPubMedCentral
17.
Zurück zum Zitat Hilbert-Carius P, Schwarzkopf D, Reinhart K, Hartog CS, Lefering R, Bernhard M, Struck MF (2018) Synthetic colloid resuscitation in severely injured patients: analysis of a nationwide trauma registry (TraumaRegister DGU). Sci Rep 8(1):11567PubMedPubMedCentral Hilbert-Carius P, Schwarzkopf D, Reinhart K, Hartog CS, Lefering R, Bernhard M, Struck MF (2018) Synthetic colloid resuscitation in severely injured patients: analysis of a nationwide trauma registry (TraumaRegister DGU). Sci Rep 8(1):11567PubMedPubMedCentral
18.
Zurück zum Zitat Schortgen F, Girou E, Deye N, Brochard L (2008) The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 34(12):2157–2168PubMed Schortgen F, Girou E, Deye N, Brochard L (2008) The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 34(12):2157–2168PubMed
19.
Zurück zum Zitat Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D, Hartog C, Reinhart K (2009) Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 35(9):1539–1547PubMed Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D, Hartog C, Reinhart K (2009) Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 35(9):1539–1547PubMed
20.
Zurück zum Zitat Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358(2):125–139PubMed Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358(2):125–139PubMed
21.
Zurück zum Zitat Kash BK, Podolyak A, Makarova N, Dalton JE, Sessler DI, Kurz A (2014) Effect of hydroxyethyl starch on postoperative kidney function in patients having noncardiac surgery. Anesthesiology 121(4):730–739 Kash BK, Podolyak A, Makarova N, Dalton JE, Sessler DI, Kurz A (2014) Effect of hydroxyethyl starch on postoperative kidney function in patients having noncardiac surgery. Anesthesiology 121(4):730–739
22.
Zurück zum Zitat Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379PubMed Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379PubMed
24.
Zurück zum Zitat Lefering R, Paffrath T, Nienaber U (2014) The TraumaRegister DGU® as data source for monitoring severe injuries. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57(6):660–665PubMed Lefering R, Paffrath T, Nienaber U (2014) The TraumaRegister DGU® as data source for monitoring severe injuries. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57(6):660–665PubMed
25.
Zurück zum Zitat Lefering R (2009) Development and validation of the revised injury severity classification score for severely injured patients. Eur J Trauma Emerg Surg 35(5):437–447PubMed Lefering R (2009) Development and validation of the revised injury severity classification score for severely injured patients. Eur J Trauma Emerg Surg 35(5):437–447PubMed
26.
Zurück zum Zitat American Thoracic Society (2004) Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 170(11):1247–1259 American Thoracic Society (2004) Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 170(11):1247–1259
28.
Zurück zum Zitat Qureshi SH, Rizvi SI, Patel NN, Murphy GJ (2016) Meta-analysis of colloids versus crystalloids in critically ill, trauma and surgical patients. Br J Surg 103(1):14–26PubMed Qureshi SH, Rizvi SI, Patel NN, Murphy GJ (2016) Meta-analysis of colloids versus crystalloids in critically ill, trauma and surgical patients. Br J Surg 103(1):14–26PubMed
29.
Zurück zum Zitat Rochwerg B, Alhazzani W, Gibson A, Ribic CM, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip W, Li G, Wang M, Włudarczyk A, Zhou Q, Annane D, Cook DJ, Jaeschke R, Guyatt GH (2015) Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med 41(9):1561–1571PubMed Rochwerg B, Alhazzani W, Gibson A, Ribic CM, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip W, Li G, Wang M, Włudarczyk A, Zhou Q, Annane D, Cook DJ, Jaeschke R, Guyatt GH (2015) Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med 41(9):1561–1571PubMed
30.
Zurück zum Zitat Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J (2013) Hydroxyethyl starch 130/0.38‑0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839PubMedPubMedCentral Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J (2013) Hydroxyethyl starch 130/0.38‑0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839PubMedPubMedCentral
31.
Zurück zum Zitat Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S (2013) Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 39(4):558–568PubMed Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S (2013) Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 39(4):558–568PubMed
32.
Zurück zum Zitat Patel A, Waheed U, Brett SJ (2013) Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 39(5):811–822PubMed Patel A, Waheed U, Brett SJ (2013) Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 39(5):811–822PubMed
33.
Zurück zum Zitat Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip WC, Li G, Wang M, Wludarczyk A, Zhou Q, Guyatt GH, Cook DJ, Jaeschke R, Annane D (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161(5):347–355PubMed Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip WC, Li G, Wang M, Wludarczyk A, Zhou Q, Guyatt GH, Cook DJ, Jaeschke R, Annane D (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161(5):347–355PubMed
34.
Zurück zum Zitat Wiedermann CJ (2016) Low-quality trials as a source of heterogeneity in the association of hydroxyethyl starch 130/0.4 or 0.42 with excess mortality in sepsis. Chin Med J (Engl) 129(1):116–117 Wiedermann CJ (2016) Low-quality trials as a source of heterogeneity in the association of hydroxyethyl starch 130/0.4 or 0.42 with excess mortality in sepsis. Chin Med J (Engl) 129(1):116–117
35.
Zurück zum Zitat Orbegozo Cortés D, Gamarano Barros T, Njimi H, Vincent JL (2015) Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression. Anesth Analg 120(2):389–402PubMed Orbegozo Cortés D, Gamarano Barros T, Njimi H, Vincent JL (2015) Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression. Anesth Analg 120(2):389–402PubMed
36.
Zurück zum Zitat Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367(20):1901–1911PubMed Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367(20):1901–1911PubMed
37.
Zurück zum Zitat Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367(2):124–134PubMed Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367(2):124–134PubMed
38.
Zurück zum Zitat Tao JP, Huang QQ, Huang HQ, Yang JJ, Shi M, Zhou Y, Wan LJ, Zhou C, Ou YJ, Tong YY, Yang DG, Si YY (2015) Effects of goal-directed fluid therapy with different lactated Ringer’s: hydroxyethyl starch ratios in hemorrhagic shock dogs. Genet Mol Res 14(2):6649–6663PubMed Tao JP, Huang QQ, Huang HQ, Yang JJ, Shi M, Zhou Y, Wan LJ, Zhou C, Ou YJ, Tong YY, Yang DG, Si YY (2015) Effects of goal-directed fluid therapy with different lactated Ringer’s: hydroxyethyl starch ratios in hemorrhagic shock dogs. Genet Mol Res 14(2):6649–6663PubMed
39.
Zurück zum Zitat Hüter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, Amann KU, Marx G (2009) Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 13(1):R23PubMedPubMedCentral Hüter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, Amann KU, Marx G (2009) Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 13(1):R23PubMedPubMedCentral
40.
Zurück zum Zitat Wiedermann CJ (2016) Impairment of innate immune function by hydroxyethyl starch. Br J Anaesth 117(2):260PubMed Wiedermann CJ (2016) Impairment of innate immune function by hydroxyethyl starch. Br J Anaesth 117(2):260PubMed
41.
Zurück zum Zitat Wiedermann CJ, Joannidis M (2014) Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med 40(2):160–170PubMed Wiedermann CJ, Joannidis M (2014) Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med 40(2):160–170PubMed
42.
Zurück zum Zitat Rasmussen KC, Secher NH, Pedersen T (2016) Effect of perioperative crystalloid or colloid fluid therapy on hemorrhage, coagulation competence, and outcome: a systematic review and stratified meta-analysis. Medicine (Baltimore) 95(31):e4498 Rasmussen KC, Secher NH, Pedersen T (2016) Effect of perioperative crystalloid or colloid fluid therapy on hemorrhage, coagulation competence, and outcome: a systematic review and stratified meta-analysis. Medicine (Baltimore) 95(31):e4498
43.
Zurück zum Zitat Coppola S, Froio S, Chiumello D (2014) Fluid resuscitation in trauma patients: what should we know? Curr Opin Crit Care 20(4):444–450PubMed Coppola S, Froio S, Chiumello D (2014) Fluid resuscitation in trauma patients: what should we know? Curr Opin Crit Care 20(4):444–450PubMed
44.
Zurück zum Zitat Kong DY, Hao LR, Zhang L, Li QG, Zhou JH, Shi SZ, Zhu F, Geng YQ, Chen XM (2015) Comparison of two fluid solutions for resuscitation in a rabbit model of crush syndrome. Clin Exp Nephrol 19(6):1015–1023PubMed Kong DY, Hao LR, Zhang L, Li QG, Zhou JH, Shi SZ, Zhu F, Geng YQ, Chen XM (2015) Comparison of two fluid solutions for resuscitation in a rabbit model of crush syndrome. Clin Exp Nephrol 19(6):1015–1023PubMed
45.
Zurück zum Zitat Ferreira EL, Terzi RG, Silva WA, de Moraes AC (2005) Early colloid replacement therapy in a near-fatal model of hemorrhagic shock. Anesth Analg 101(6):1785–1791PubMed Ferreira EL, Terzi RG, Silva WA, de Moraes AC (2005) Early colloid replacement therapy in a near-fatal model of hemorrhagic shock. Anesth Analg 101(6):1785–1791PubMed
46.
Zurück zum Zitat Masoumi K, Forouzan A, Darian AA, Rafaty Navaii A (2016) Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. J Clin Med Res 8(11):815–818PubMedPubMedCentral Masoumi K, Forouzan A, Darian AA, Rafaty Navaii A (2016) Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. J Clin Med Res 8(11):815–818PubMedPubMedCentral
47.
Zurück zum Zitat Pape A, Kutschker S, Kertscho H, Stein P, Horn O, Lossen M, Zwissler B, Habler O (2012) The choice of the intravenous fluid influences the tolerance of acute normovolemic anemia in anesthetized domestic pigs. Crit Care 16(2):R69PubMedPubMedCentral Pape A, Kutschker S, Kertscho H, Stein P, Horn O, Lossen M, Zwissler B, Habler O (2012) The choice of the intravenous fluid influences the tolerance of acute normovolemic anemia in anesthetized domestic pigs. Crit Care 16(2):R69PubMedPubMedCentral
48.
Zurück zum Zitat Konrad FM, Mik EG, Bodmer SI, Ates NB, Willems HF, Klingel K, de Geus HR, Stolker RJ, Johannes T (2013) Acute normovolemic hemodilution in the pig is associated with renal tissue edema, impaired renal microvascular oxygenation, and functional loss. Anesthesiology 119(2):256–269PubMed Konrad FM, Mik EG, Bodmer SI, Ates NB, Willems HF, Klingel K, de Geus HR, Stolker RJ, Johannes T (2013) Acute normovolemic hemodilution in the pig is associated with renal tissue edema, impaired renal microvascular oxygenation, and functional loss. Anesthesiology 119(2):256–269PubMed
49.
Zurück zum Zitat Silva PL, Güldner A, Uhlig C, Carvalho N, Beda A, Rentzsch I, Kasper M, Wiedemann B, Spieth PM, Koch T, Capelozzi VL, Pelosi P, Rocco PR, de Abreu MG (2013) Effects of intravascular volume replacement on lung and kidney function and damage in nonseptic experimental lung injury. Anesthesiology 118(2):395–408PubMed Silva PL, Güldner A, Uhlig C, Carvalho N, Beda A, Rentzsch I, Kasper M, Wiedemann B, Spieth PM, Koch T, Capelozzi VL, Pelosi P, Rocco PR, de Abreu MG (2013) Effects of intravascular volume replacement on lung and kidney function and damage in nonseptic experimental lung injury. Anesthesiology 118(2):395–408PubMed
50.
Zurück zum Zitat Meybohm P, Van Aken H, De Gasperi A, De Hert S, Della Rocca G, Girbes AR, Gombotz H, Guidet B, Hasibeder W, Hollmann MW, Ince C, Jacob M, Kranke P, Kozek-Langenecker S, Loer SA, Martin C, Siegemund M, Wunder C, Zacharowski K (2013) Re-evaluating currently available data and suggestions for planning randomized controlled studies regarding the use of hydroxyethyl starch in critically ill patients—a multidisciplinary statement. Crit Care 17(4):R166PubMedPubMedCentral Meybohm P, Van Aken H, De Gasperi A, De Hert S, Della Rocca G, Girbes AR, Gombotz H, Guidet B, Hasibeder W, Hollmann MW, Ince C, Jacob M, Kranke P, Kozek-Langenecker S, Loer SA, Martin C, Siegemund M, Wunder C, Zacharowski K (2013) Re-evaluating currently available data and suggestions for planning randomized controlled studies regarding the use of hydroxyethyl starch in critically ill patients—a multidisciplinary statement. Crit Care 17(4):R166PubMedPubMedCentral
Metadaten
Titel
Fluid resuscitation after severe trauma injury
U-shaped associations between tetrastarch dose and survival time or frequency of acute kidney failure
verfasst von
E. Fleischhacker
H. Trentzsch
D. Kuppinger
S. Piltz
F. Beyer
F. Meigel
T. Kammerer
M. Rehm
W. H. Hartl, MD
Publikationsdatum
06.11.2019
Verlag
Springer Medizin
Erschienen in
Medizinische Klinik - Intensivmedizin und Notfallmedizin / Ausgabe 7/2020
Print ISSN: 2193-6218
Elektronische ISSN: 2193-6226
DOI
https://doi.org/10.1007/s00063-019-00625-7

Weitere Artikel der Ausgabe 7/2020

Medizinische Klinik - Intensivmedizin und Notfallmedizin 7/2020 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.